-
Catalyst Health Solutions Reports EPS of $0.52 vs. $0.49 Estimate; Revenues $1.12B vs. $1.13B Estimate (CHSI)
Wednesday, May 4, 2011 - 5:09pm | 23Catalyst Health Solutions (NASDAQ: CHSI) Reports EPS of $0.52 vs. $0.49 Estimate; Revenues $1.12B vs. $1.13B Estimate
-
Providence Services Reports EPS of $0.44 vs. $0.47 Estimate; Revenues $227.8M vs. $226.15M Estimate
Wednesday, May 4, 2011 - 4:48pm | 22Providence Services (NASDAQ: PRSC) Reports EPS of $0.44 vs. $0.47 Estimate; Revenues $227.8M vs. $226.15M Estimate
-
Top Percentage Gainers and Losers as of 12pm 5/04/11 (VSEA, GMCR, BEAT, VCLK, SGI, GLUU, AXTI, KNDI, QSFT, SWSH, SONS, WWWW, MOTR, OPEN, AMAT)
Wednesday, May 4, 2011 - 12:03pm | 494Best 1) Varian Semiconductor Equipment Associates (NASDAQ: VSEA): Trading up 51.3% from yesterday's close to $61.37. Varian is being acquired by Applied Materials (NASDAQ: AMAT) for $63 per share in cash. The deal is valued at $4.9 billion. 2) Silicon Graphics International (NASDAQ: SGI): Trading...
-
Quest Diagnostics Announces Successful Tender Offer and Commencement of a Subsequent Offering Period for Shares of Celera (DGX, CRA)
Wednesday, May 4, 2011 - 8:07am | 237Quest Diagnostics Incorporated (NYSE: DGX), the world's leading provider of diagnostic testing, information and services, announced today that Spark Acquisition Corporation, its wholly owned subsidiary, successfully completed the cash tender offer for all outstanding shares of common stock of...
-
CEOWORLD Most Actives Technology stocks on 5/4/11- EXAR, CY, SANM, REFR, JNPR, SIFY, CELL, TDSC, REDF, RNOW, AAPL, MSFT, INTC, ORCL, RIMM
Wednesday, May 4, 2011 - 6:25am | 1490Gainers (% price change): Exar Corporation (EXAR) a fabless semiconductor company that designs, sub-contracts manufacturing and sells differentiated silicon, software and subsystem solutions for industrial, telecom, networking and storage applications is trading at a price of $6.59, a dramatic...
-
Citi Reports DaVita 1Q11 Results Nicely Inline
Tuesday, May 3, 2011 - 8:41am | 102According to Citi, DaVita (NYSE: DVA) 1Q11 results are nicely ahead and guidance in inline. Citi said that DVA's 1Q11 revenues, EBITDA, operating income and EPS were all above consensus expectations on inline 4% non-acquired treatment growth. “We believe expectations were fairly high coming into...
-
Landauer Reports EPS of $0.85 vs. $0.75 Estimate; Revenues $32.3M vs. $32.94M Estimate
Tuesday, May 3, 2011 - 8:11am | 21Landauer (NYSE: LDR) Reports EPS of $0.85 vs. $0.75 Estimate; Revenues $32.3M vs. $32.94M Estimate
-
Quest Diagnostics Announces One Day Extension of Offer to Acquire Celera to 5pm Today (DGX)
Tuesday, May 3, 2011 - 8:08am | 97Quest Diagnostics Incorporated (NYSE: DGX), the world's leading provider of diagnostic testing, information and services, announced today that Spark Acquisition Corporation, its wholly owned subsidiary, has extended the expiration of its tender offer to acquire all outstanding shares of common...
-
Jefferies Upgrades PT On DaVita To $101 (DVA)
Tuesday, May 3, 2011 - 8:03am | 115Jefferies has upgraded its price target on DaVita (NYSE: DVA) from $95 to $101 in a research report published today. In the report, Jefferies states, "Our $101 PT is based on a 5-year DCF analysis that assumes a WACC of 7.3% and a terminal EBITDA-MI multiple of 8.5x (in-line with historical...
-
Amedisys Signs Definitive Agreement to Acquire Hackensack University Medical Center Hospice Agency and Inpatient Unit (AMED)
Tuesday, May 3, 2011 - 7:28am | 101Amedisys (NASDAQ: AMED), one of America's leading home health and hospice companies, today announced that it has signed a definitive agreement to acquire the hospice operations of Hackensack University Medical Center. Hospice of Hackensack, with annual revenue of approximately $5 million in 2010,...
-
BioScrip Reports Q1 EPS of $0.05 vs. $(0.01) Estimate; Revenues $439.3M vs. $440.8M Estimate (BIOS)
Tuesday, May 3, 2011 - 7:06am | 22BioScrip (NASDAQ: BIOS) Reports Q1 EPS of $0.05 vs. $(0.01) Estimate; Revenues $439.3M vs. $440.8M Estimate
-
Jefferies Raises PT On DaVita To $101
Tuesday, May 3, 2011 - 6:18am | 26Jefferies & Company has raised the price target on DaVita (NYSE: DVA) from $95 to $101 and maintains its Hold rating.
-
DaVita Reports EPS of $0.96 vs. $0.95 Estimate; Revenues $1.61B vs. $1.6B Estimate
Monday, May 2, 2011 - 5:00pm | 21DaVita (NYSE: DVA) Reports EPS of $0.96 vs. $0.95 Estimate; Revenues $1.61B vs. $1.6B Estimate
-
VITAS Healthcare Corporation Acquires Family Comfort Hospice; Terms Not Disclosed
Monday, May 2, 2011 - 11:09am | 76Chemed Corporation (NYSE: CHE) today announced that its VITAS Healthcare Corporation subsidiary has acquired the operating assets of Family Comfort Hospice based in Alabama, effective April 29, 2011. This acquisition adds three Central-Alabama locations serving ten counties to VITAS' network of...
-
CEOWORLD Top 10 Large Cap Stocks in April: ERIC, VMW, FMS, BBBY, WYNN, KKR, BIIB, LTD, CHU, ZNH
Monday, May 2, 2011 - 9:34am | 1246China Unicom (Hong Kong) Limited (ADR) (NYSE:CHU)- Technical indicators for the stock are Bullish and S&P gives CHU a weak 2 STARS (out of 5) sell rating. For a hedged play on this stock, look at the Oct '11 $20.00 covered call for a net debit in the $18.36 area. That is also the break-even...